Kiniksa Pharmaceuticals International Plc (KNSA)

47.27 +1.90 (+4.19%) USD  |  NASDAQ  |  Mar 04, 16:00
47.43 +0.16 (+0.34%) After-Hours: 20:00
More

Kiniksa Pharmaceuticals International Stock Based Compensation (5 Year Growth)

Stock Based Compensation (5 Year Growth) Chart

View Stock Based Compensation (5 Year Growth) for KNSA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (5 Year Growth) Range, Past 5 Years

View Stock Based Compensation (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (5 Year Growth) Benchmarks

View Stock Based Compensation (5 Year Growth) Benchmarks
Start Trial
Marker Therapeutics, Inc. Upgrade
NovoCure Ltd. Upgrade
LivaNova Plc Upgrade
Alterola Biotech, Inc. --
Akanda Corp. --